Adam Kaplin
2021
In 2021, Adam Kaplin earned a total compensation of $5.2M as Chief Scientific Officer at Akers Biosciences, a 1,350% increase compared to previous year.
Compensation breakdown
| Bonus | $126,724 |
|---|---|
| Salary | $250,000 |
| Stock Awards | $4,854,000 |
| Total | $5,230,724 |
Kaplin received $4.9M in stock awards, accounting for 93% of the total pay in 2021.
Kaplin also received $126.7K in bonus and $250K in salary.
Rankings
In 2021, Adam Kaplin's compensation ranked 2,480th out of 12,415 executives tracked by ExecPay. In other words, Kaplin earned more than 80.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,480 out of 12,415 | 80th |
Division Manufacturing | 985 out of 5,505 | 82nd |
Major group Chemicals And Allied Products | 378 out of 2,375 | 84th |
Industry group Drugs | 330 out of 2,096 | 84th |
Industry In Vitro and In Vivo Diagnostic Substances | 5 out of 61 | 92nd |
Source: SEC filing on October 26, 2022.
Kaplin's colleagues
We found three more compensation records of executives who worked with Adam Kaplin at Akers Biosciences in 2021.
News
Akers Biosciences Chief Medical Officer Christopher Chapman's 2023 pay jumps 1,002% to $2.9M
November 1, 2024
Akers Biosciences CSO Adam Kaplin's 2022 pay falls 93% to $354K
June 30, 2023
Akers Biosciences CSO Adam Kaplin's 2021 pay jumps 1,350% to $5.2M
October 26, 2022
Akers Biosciences CEO Christopher Schreiber's 2020 pay jumps 1,909% to $1.1M
November 22, 2021